MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 199 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.76 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,669,421 | -36.9% | 18,300 | 0.0% | 0.90% | -30.1% |
| Q2 2023 | $4,227,300 | +1114.7% | 18,300 | +242.1% | 1.29% | +1049.1% |
| Q3 2022 | $348,000 | -93.5% | 5,350 | +1296.9% | 0.11% | +100.0% |
| Q2 2022 | $5,350,000 | +5.6% | 383 | -92.8% | 0.06% | -95.1% |
| Q1 2022 | $5,066,000 | +208.7% | 5,350 | -46.5% | 1.14% | +46.4% |
| Q3 2018 | $1,641,000 | -41.2% | 10,000 | 0.0% | 0.78% | -27.2% |
| Q2 2018 | $2,790,000 | +21.7% | 10,000 | -60.0% | 1.07% | +32.5% |
| Q4 2017 | $2,293,000 | – | 25,000 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 1,402,250 | $93,614,000 | 4.00% |
| Parkman Healthcare Partners LLC | 30,000 | $2,003,000 | 0.93% |
| ARMISTICE CAPITAL, LLC | 216,000 | $14,420,000 | 0.89% |
| Avoro Capital Advisors LLC | 349,000 | $23,299,000 | 0.79% |
| Rock Springs Capital Management LP | 250,000 | $16,690,000 | 0.69% |
| Capital Impact Advisors, LLC | 24,351 | $1,626,000 | 0.68% |
| Baker Brothers Advisors | 1,499,212 | $100,087,000 | 0.62% |
| EWG Elevate Inc. | 11,086 | $740,000 | 0.56% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $801,000 | 0.54% |
| DAFNA Capital Management LLC | 13,600 | $908,000 | 0.38% |